These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 34006305)
1. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer. Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305 [TBL] [Abstract][Full Text] [Related]
2. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway. Zhu S; Sun J; Liu X; Shao H; Feng C; Wang Z; Zheng X; Wei S Mol Cell Biol; 2022 Jun; 42(6):e0018821. PubMed ID: 35499320 [TBL] [Abstract][Full Text] [Related]
3. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis. Guo C; Zhang M; Jin X; Zhu C; Qian J; Tao M Cell Biochem Funct; 2024 Jun; 42(4):e4020. PubMed ID: 38702967 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma. Feng Z; Chen R; Huang N; Luo C Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer. Zhang X; Li F; Zhou Y; Mao F; Lin Y; Shen S; Li Y; Zhang S; Sun Q Cell Death Dis; 2021 Jun; 12(7):627. PubMed ID: 34145213 [TBL] [Abstract][Full Text] [Related]
6. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis. Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982 [TBL] [Abstract][Full Text] [Related]
7. MiR-296-3p inhibits cell proliferation by the SOX4-Wnt/βcatenin pathway in triple-negative breast cancer. Tian D; Luo L; Wang T; Qiao J J Biosci; 2021; 46():. PubMed ID: 34785625 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer. Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219 [TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1). Mou Y; Sun Q Bioengineered; 2022 Jan; 13(1):746-758. PubMed ID: 34859735 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway. Qiao Y; Wang B; Yan Y; Niu L Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485 [TBL] [Abstract][Full Text] [Related]
11. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling. Guan B; Ma J; Yang Z; Yu F; Yao J Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352 [TBL] [Abstract][Full Text] [Related]
12. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD. Wu D; Jia H; Zhang Z; Li S Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis. Tao W; Sun W; Zhu H; Zhang J Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732 [TBL] [Abstract][Full Text] [Related]
14. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC. Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550 [TBL] [Abstract][Full Text] [Related]
15. Exosomal lncRNA USP30-AS1 activates the Wnt/β-catenin signaling pathway to promote cervical cancer progression via stabilization of β-catenin by USP30. Chi C; Tang X; Liu W; Zhou Y; Jiang R; Chen Y; Li M Biotechnol J; 2024 Jul; 19(7):e2300653. PubMed ID: 39014929 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis. Zhang J; Zhang L; Wang J; Zhao J; Zhao X; Zhang C; Han P; Geng C Hum Cell; 2022 May; 35(3):909-923. PubMed ID: 35179718 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway. Xiong L; Tang Y; Tang J; Liu Z; Wang X Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357 [No Abstract] [Full Text] [Related]
18. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis. Han C; Fu Y; Zeng N; Yin J; Li Q Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-124-3p.1 promotes cell proliferation through Axin1-dependent Wnt signaling pathway and predicts a poor prognosis of triple-negative breast cancer. Yang W; Cui G; Ding M; Yang M; Dai D J Clin Lab Anal; 2020 Jul; 34(7):e23266. PubMed ID: 32125723 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/β-catenin axis. Huang L; Li X; Ye H; Liu Y; Liang X; Yang C; Hua L; Yan Z; Zhang X J Exp Clin Cancer Res; 2020 Apr; 39(1):63. PubMed ID: 32293515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]